US FDA Decision: A New Milestone for IQOS

The FDA’s decisions show that IQOS is a fundamentally different product compared to cigarettes. IQOS is a better choice for adults who would otherwise continue smoking. By heating instead burning tobacco, IQOS significantly reduces the production of harmful or potentially harmful chemicals compared to cigarette smoke.

For the past 10 years, we built a team of more than 400 scientists and R&D experts and have significantly invested towards one goal: creating an alternative to cigarettes for those adult smokers who want a better choice than continued smoking.
So we are proud to celebrate this milestone on our journey, together we aim to prove ourselves step by step and continue delivering on our promises.

Important information: IQOS is not risk-free. It delivers nicotine, which is addictive.

*Source: PMI 3-month reduced exposure studies conducted in Japan and the US in near real world conditions. These studies measured exposure to 15 harmful chemicals, and compared to the levels observed in smokers who switched to IQOS with levels measured in smokers who continued to smoke cigarettes.

**Source:  FDA’s marketing order for the IQOS system dated July 7, 2020.